Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 Feb;63(2):367–375.

Late-onset rubella syndrome: coexistence of immune complex disease and defective cytotoxic effector cell function.

H Verder, E Dickmeiss, S Haahr, E Kappelgaard, J Leerbøy, A Møller-Larsen, H Nielsen, P Platz, C Koch
PMCID: PMC1577388  PMID: 2938855

Abstract

We studied a classical case of late-onset rubella syndrome characterized by multi-organ disease and persistence of live rubella virus in spite of high titres of specific antirubella antibodies and presence of large amounts of circulating immune complexes. When first studied at the age of 5 months there was a low proportion of T8+ lymphocytes. Functional studies revealed decreased activity of K and NK cells as well as alloreactive direct cytotoxic cells (CTL). Removal of cell-bound immunoglobulin and immune complexes tended to improve K and NK cell function in vitro. Plasma exchange transfusions carried out at 9 months of age resulted in clinical improvement. Normalization of cytotoxic effector cell functions and cessation of viremia accompanied recovery from active disease. The results indicate that defective cytotoxic effector cell function is the primary cause for the defective virus elimination in this syndrome.

Full text

PDF
367

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dickmeiss E., Søeberg B., Svejgaard A. HLA restriction of dinitrophenyl-specific cell-mediated cytotoxicity in vitro. Scand J Immunol. 1981 Sep;14(3):293–302. doi: 10.1111/j.1365-3083.1981.tb00567.x. [DOI] [PubMed] [Google Scholar]
  2. Greenberg S. B., Criswell B. S., Six H. R., Couch R. B. Lymphocyte cytotoxicity to influenza virus-infected cells: response to vaccination and virus infection. Infect Immun. 1978 Jun;20(3):640–645. doi: 10.1128/iai.20.3.640-645.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Haahr S., Rasmussen L., Merigan T. C. Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus. Infect Immun. 1976 Jul;14(1):47–54. doi: 10.1128/iai.14.1.47-54.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kappelgaard E., Nielsen H., Bech K., Bliddal H., Feldt-Rasmussen U., Thomsen M. Circulating immune complexes in Hashimoto's thyroiditis. Correlation to HLA and autoantibodies. Allergy. 1983 Aug;38(6):433–439. doi: 10.1111/j.1398-9995.1983.tb05086.x. [DOI] [PubMed] [Google Scholar]
  5. Kay H. D., Bonnard G. D., West W. H., Herberman R. B. A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol. 1977 Jun;118(6):2058–2066. [PubMed] [Google Scholar]
  6. LEERHOY J. CYTOPATHIC EFFECT OF RUBELLA VIRUS IN A RABBIT-CORNEA CELL LINE. Science. 1965 Aug 6;149(3684):633–634. doi: 10.1126/science.149.3684.633. [DOI] [PubMed] [Google Scholar]
  7. Larsson A., Forsgren M., Hård af Segerstad S., Strander H., Cantell K. Administration of interferon to an infant with congenital rubella syndrome involving persistent viremia and cutaneous vasculitis. Acta Paediatr Scand. 1976 Jan;65(1):105–110. doi: 10.1111/j.1651-2227.1976.tb04415.x. [DOI] [PubMed] [Google Scholar]
  8. Lee J. C., Sigel M. M. A differential effect of IgM and IgG antibodies on the blastogenic response of lymphocytes to rubella virus. Cell Immunol. 1974 Jul;13(1):22–31. doi: 10.1016/0008-8749(74)90223-8. [DOI] [PubMed] [Google Scholar]
  9. Mogensen K. E., Pyhälä L., Törmä E., Cantell K. No evidence for a carbohydrate moiety affecting the clearance of circulating human leukocyte interferon in rabbits. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Jun;82(3):305–310. doi: 10.1111/j.1699-0463.1974.tb02331.x. [DOI] [PubMed] [Google Scholar]
  10. Pierce G. F., Brovall C., Schacter B. Z., Polmar S. H. Impaired culture generated cytotoxicity with preservation of spontaneous natural killer-cell activity in cartilage-hair hypoplasia. J Clin Invest. 1983 Jun;71(6):1737–1743. doi: 10.1172/JCI110928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Platz P., Fog T., Morling N., Svejgaard A., Sonderstrup G., Ryder L. P., Thomsen M., Jersild C. Immunological in vitro parameters in patients with multiple sclerosis and in normal individuals. Acta Pathol Microbiol Scand C. 1976 Dec;84C(6):501–510. doi: 10.1111/j.1699-0463.1976.tb00062.x. [DOI] [PubMed] [Google Scholar]
  12. Tardieu M., Grospierre B., Durandy A., GAriscelli C. Circulating immune complexes containing rubella antigens in late-onset rubella syndrome. J Pediatr. 1980 Sep;97(3):370–373. doi: 10.1016/s0022-3476(80)80183-1. [DOI] [PubMed] [Google Scholar]
  13. Thomsen M., Hansen H. E., Dickmeiss E. MLC and CML studies in the family of a pair of HLA haploidentical chimeric twins. Scand J Immunol. 1977;6(5):523–528. doi: 10.1111/j.1365-3083.1977.tb02115.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Weil M. L., Itabashi H., Cremer N. E., Oshiro L., Lennette E. H., Carnay L. Chronic progressive panencephalitis due to rubella virus simulating subacute sclerosing panencephalitis. N Engl J Med. 1975 May 8;292(19):994–998. doi: 10.1056/NEJM197505082921903. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES